Thursday, October 31, 2013
Publication and contact
Reprogramming in vivo
to generate totipotent induced pluripotent stem (iPS) cells
In vivo reprogramming in mice could be used to generate
highly plastic iPS cells that can efficiently contribute to extraembryonic
tissue such as placenta. Mice were engineered to express four
doxycycline-inducible reprogramming factors: Oct4,
In these mice, doxycycline led to the formation of
iPS cells in multiple organs that originated from multiple cell types. The in
vivo-generated iPS cells were more efficient at forming embryonic and
extraembryonic tissues than embryonic stem cells or in vitro-generated
iPS cells. Next steps include understanding the mechanism of in vivo
reprogramming and why the resulting iPS cells show greater totipotency than
other stem cell lines.
Published online Oct. 31, 2013
Patent application filed;
available for licensing through the Botín
Contact: Miriam Zeini, Botín
Foundation, Madrid, Spain
Abad, M. et al. Nature;
published online Sept. 11, 2013;
Contact: Manuel Serrano, Spanish National Cancer Research
Centre (CNIO), Madrid, Spain
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]